Spectrochemical analysis of liquid biopsy harnessed to multivariate analysis towards breast cancer screening

Freitas, Daniel L. D., Câmara, Ingrid M., Silva, Priscila P., Wanderley, Nathália R. S., Alves, Maria B. C., Medeiros-De-morais, Camilo De lelis orcid iconORCID: 0000-0003-2573-787X, Martin, Francis L orcid iconORCID: 0000-0001-8562-4944, Lajus, Tirzah B. P. and Lima, Kassio M. G. (2020) Spectrochemical analysis of liquid biopsy harnessed to multivariate analysis towards breast cancer screening. Scientific Reports, 10 (1).

[thumbnail of Version of Record]
PDF (Version of Record) - Published Version
Available under License Creative Commons Attribution.


Official URL: https://doi.org/10.1038/s41598-020-69800-7


Mortality due to breast cancer could be reduced via screening programs where preliminary clinical tests employed in an asymptomatic well-population with the objective of identifying cancer biomarkers could allow earlier referral of women with altered results for deeper clinical analysis and treatment. The introduction of well-population screening using new and less-invasive technologies as a strategy for earlier detection of breast cancer is thus highly desirable. Herein, spectrochemical analyses harnessed to multivariate classification techniques are used as a bio-analytical tool for a Breast Cancer Screening Program using liquid biopsy in the form of blood plasma samples collected from 476 patients recruited over a 2-year period. This methodology is based on acquiring and analysing the spectrochemical fingerprint of plasma samples by attenuated total reflection Fourier-transform infrared spectroscopy; derived spectra reflect intrinsic biochemical composition, generating information on nucleic acids, carbohydrates, lipids and proteins. Excellent results in terms of sensitivity (94%) and specificity (91%) were obtained using this method in comparison with traditional mammography (88–93% and 85–94%, respectively). Additional advantages such as better disease prognosis thus allowing a more effective treatment, lower associated morbidity, fewer false-positive and false-negative results, lower-cost, and higher analytical frequency make this method attractive for translation to the clinical setting.

Repository Staff Only: item control page